From saccharin in the 19th century to stevia and monk fruit in the 21st, researchers and the food industry have long sought a ...

A sweeping review of more than 2,500 studies reveals that despite booming public enthusiasm, cannabis has strong scientific ...

The coming era of biosecurity will demand a broader and more adaptive approach as AI, powerful biological engineering ...

The global Anti-Wrinkle Agents Market  is on a remarkable growth trajectory, poised to more than double in size from an estimated USD 4,802.4 Million in 2025 to over USD 10,203.6 Million by 2035, at a ...

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today presented clinical data for CTD402, its investigational allogeneic anti-CD7 CAR ...

Biotechnology can be used in the packaging of beauty products and has a significant sustainability impact that is good for ...

Biotech ETFs offer diversified exposure to multiple biotech stocks, reducing individual investment risk. Top biotech ETFs, like iShares and SPDR S&P, have large assets and low expense ratios.

Phototropin responds to blue light and regulates starch storage by activating or deactivating PMSK1, a protein that controls starch synthesis. Blue light reduces starch accumulation, while red light ...

WASHINGTON, Jan 15 (Reuters) - The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related technology because of national security concerns ...

The market for genetically modified food is anticipated to expand significantly between 2023 and 2033, with a CAGR of 6.5%. The market value significantly increased from US$ 109,173.6 million in 2023 ...

MAIA Biotechnology Inc. (NYSE: MAIA), a clinical-stage biopharmaceutical company focused on developing and commercializing targeted immunotherapies for cancer, reported positive interim survival ...